Although these studies identified several inactivating PRLR variants, some activity was retained by all the variants, in contrast to the hyperprolactinaemia-associated His188Arg variant (Newey et al. 2013), which abolishes signalling. The gene discussed is PRLR; the disease is hyperpituitarism.